Editor - Neuro-Oncology Advances

Dr. Gelareh Zadeh - Editor-in-Chief of the Neuro-Oncology Advances Journal

[Editor - Neuro-Oncology Advances @EditorNeuro]

We welcome working with you on manuscripts in any area of #braintumor #CancerResearch #cancercare #spinetumors #metastases #pediatricbraintumor #molecularpathology #Neurosurgery #neuroscience of #braincancer & more

[email protected]
https://t.co/EwuKQCEH6k

[Farshad Nassiri @FarshadNassiri]

Deeply honored and grateful 🙏 to be selected as SNO Executive Editor for NeuroOncology Advances @EditorNeuro @NeuroOnc

Looking forward to working with EiC @wick_wolfgang, fellow dedicated editors, thoughtful authors and broad neuroonc community to amplify #impactful #research.

[Editor - Neuro-Oncology Advances @EditorNeuro]

As my term as #EIC has come to an end, I want to thank everyone who has made #NOA a successful internationally reocgnized journal.

Thank you to our readers, authors, reviewers, editors, @OUPAcademic, @NeuroOnc & @EANOassociation for helping further advances in #NeuroOncology

[Editor - Neuro-Oncology Advances @EditorNeuro]

I am delighted to welcome @wick_wolfgang as the new Editor-in-Chief of #NeuroOncologyAdvances. As I pass the torch, I do so with pride in what we have built together and look forward to seeing the journal grow under his leadership.

[Editor - Neuro-Oncology Advances @EditorNeuro]

The achievements of NOA have always been the result of teamwork. Thank you to the exceptional group of executive and associate #editors I’ve had the privilege to work with over the past seven years whose dedication, insight, and commitment to quality shaped the journal.

[Editor - Neuro-Oncology Advances @EditorNeuro]

A letter from @gelarehzadeh on her term as Editor-in-Chief of #NeuroOncologyAdvances coming to a close.

[Editor - Neuro-Oncology Advances @EditorNeuro]

Our new supplement on #SingleCell Technologies is now available!

Click here for open access articles: https://t.co/SyCpLEUMP6

[Editor - Neuro-Oncology Advances @EditorNeuro]

Read the systematic literature review around disease burden and unmet needs in adults with #neurofibromatosis type 1 and #PlexiformNeurofibromas in our latest issue:

https://t.co/IUhiVuXYzq

[Editor - Neuro-Oncology Advances @EditorNeuro]

Unlike cancers with successful fusion-targeted treatments, the incidence and therapeutic potential of #GeneFusions in #glioblastoma remain unclear. This article analyzes a large genomic database to define fusion frequency and molecular associations.

https://t.co/jDdVVHC2sm

[Editor - Neuro-Oncology Advances @EditorNeuro]

Read our new review examining the interplay between key immune system components and the #microbiota in #glioblastoma development and how this understanding could facilitate the development of novel therapeutic interventions:

https://t.co/uw7A6tLKKg

[Editor - Neuro-Oncology Advances @EditorNeuro]

Our new article on the #glioblastoma #GBMdrug1000 dataset resource providing directions for future small molecule drug discovery is now available.

Read here: https://t.co/4BEEfqUEyD

[Editor - Neuro-Oncology Advances @EditorNeuro]

This study evaluates diagnostic timelines and their influencing factors, treatment patterns, and their impact on survival in patients with Primary central nervous system lymphoma (#PCNSL).

Read the full article here: https://t.co/xGuxHqOFx3

[Editor - Neuro-Oncology Advances @EditorNeuro]

What’s new in #NeuroOncology Advances?

Here are our latest #articles!

https://t.co/EwuKQCEH6k

[Editor - Neuro-Oncology Advances @EditorNeuro]

We’re pleased to offer #LaySummaries for many of our recent articles. You can read them by navigating to our latest issue and clicking the ‘Lay Summary’ drop down below the title.

https://t.co/kIG3pBk9ux

[Editor - Neuro-Oncology Advances @EditorNeuro]

The molecular tumor board case report “A case of #radiation treatment effect mimicking viable, recurrent #meningioma on #DOTATATE PET imaging” is now available in our latest issue:

https://t.co/G70g7GWEgL

[Editor - Neuro-Oncology Advances @EditorNeuro]

This recent investigation analyzed a large #genomic database to define fusion frequency and molecular associations.

Read the #LaySummary or full article here: https://t.co/kIcBpJTiph

[Editor - Neuro-Oncology Advances @EditorNeuro]

“Improved target volume delineation for #StereotacticRadiosurgery in #BrainMetastases using post-contrast 3D T1 TSE black-blood #MRI” is now available in our latest issue:

https://t.co/pUbg88T4Oy

[Editor - Neuro-Oncology Advances @EditorNeuro]

What are the clinical, morphological and molecular features of desmoplastic infantile #ganglioglioma/#astrocytoma?

Read the recent #ClinicalInvestigation:
https://t.co/NQQr97cE4i

[Editor - Neuro-Oncology Advances @EditorNeuro]

Read the study evaluating how #MolecularPathology and clinical features influence surgical outcomes in patients with WHO grade 4 #gliomas, including isocitrate dehydrogenase (#IDH)-mutant astrocytomas and IDH wild-type #glioblastomas.

https://t.co/wjDYWh7Rqx

[Editor - Neuro-Oncology Advances @EditorNeuro]

Read the article on “Age-dependent #glioma #progression and functional decline in a syngeneic #murine model: Host vulnerabilities and opportunities for targeted intervention” in our new issue:

https://t.co/Q7NE3bBKtZ

[International Consortium on Meningiomas (ICOM) @ICOMeningioma]

Thank you to the organizers of our upcoming NASBS/ICOM #Meningioma Education Day, @gelarehzadeh @FarshadNassiri @ap_landry @michaelivanmd and Paul Gardner.

You can learn more about the agenda or register as part of the @NASBSorg 2026 Meeting here: https://t.co/i27ub7VmQZ